BLT: March 2020


Featured Articles


Fintech Oversight—Collaboration Is Needed Now More Than Ever

Fintechs are here to stay as an integral player of financial services, but their success and longevity cannot be sustained without the responsible delivery of products and services. Growing risks have prompted greater regulatory focus and the need for better-defined compliance frameworks to manage risks. Anything less than robust compliance frameworks could have an immediate or long-term impact on the fintech’s credibility, bottom line, and potentially its business viability.

Business & Corporate

Getting Full Insurance Coverage for Your Actual Cyber Exposures: A Users’ Guide to the Nit and the Grit

By now, most businesses accept ongoing cyber threats as a fact of life. Some firms, accepting the reality of the threats, are deciding whether to ignore their cyber risks, fix them, or transfer them by way of insurance. This article considers this last option, specifically how you can obtain full insurance coverage for your actual cyber exposures at a fair premium.

Business & Corporate

Cyberspace Law Committee Presents Global Privacy Checklist

For lawyers who do not specialize in privacy, the ABA’s Cyberspace Law Committee’s Consumer Privacy and Data Analytics Subcommittee has assembled an international group of privacy experts and tasked them with compiling a guide to privacy laws from multiple jurisdictions around the world—the Global Privacy Checklist. The Checklist is a valuable starting point for any lawyer who counsels clients on complying with privacy laws. It serves as a pointer to the most salient of those laws in multiple jurisdictions: U.S. federal, U.S. states, Australia, Canada, the European Union’s General Data Protection Regulation, and the member states of the European Union.

Business & Corporate

Marijuana M&A: Special Due Diligence Considerations

The wave of marijuana legalization that has washed over North America in recent years has spurred an increasing number of mergers and acquisitions involving marijuana-related businesses (MRBs). Despite the surge in deal-making, cannabis remains an emerging industry that presents unique challenges, even for experienced M&A practitioners who have advised on deals in a wide range of industries. This article will discuss a few of the unique challenges for deal lawyers in marijuana M&A, including industry-specific due diligence issues and risks that may be hard to quantify and (through appropriate representations, warranties, and indemnities) limit for buy-side clients.